Literature DB >> 33041701

COVID 19: A Clinical Primer-Overview and Plaquenil/Zithromax.

Jacob Teitelbaum.   

Abstract

Entities:  

Year:  2020        PMID： 33041701      PMCID： PMC7482323     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN： 1546-993X


× No keyword cloud information.
  9 in total

1.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.

Authors:  Gerold Hoever; Lidia Baltina; Martin Michaelis; Rimma Kondratenko; Lia Baltina; Genrich A Tolstikov; Hans W Doerr; Jindrich Cinatl
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

3.  Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.

Authors:  Aartjan J W te Velthuis; Sjoerd H E van den Worm; Amy C Sims; Ralph S Baric; Eric J Snijder; Martijn J van Hemert
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

4.  Potential interventions for novel coronavirus in China: A systematic review.

Authors:  Lei Zhang; Yunhui Liu
Journal:  J Med Virol       Date:  2020-03-03       Impact factor: 2.327

5.  New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Authors:  Christian A Devaux; Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-12       Impact factor: 5.283

6.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

7.  In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Xueting Yao; Fei Ye; Miao Zhang; Cheng Cui; Baoying Huang; Peihua Niu; Xu Liu; Li Zhao; Erdan Dong; Chunli Song; Siyan Zhan; Roujian Lu; Haiyan Li; Wenjie Tan; Dongyang Liu
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

Review 8.  Antiviral effects of Glycyrrhiza species.

Authors:  Cristina Fiore; Michael Eisenhut; Rea Krausse; Eugenio Ragazzi; Donatella Pellati; Decio Armanini; Jens Bielenberg
Journal:  Phytother Res       Date:  2008-02       Impact factor: 5.878

9.  Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.

Authors:  Jonas F Ludvigsson
Journal:  Acta Paediatr       Date:  2020-04-14       Impact factor: 4.056
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.